Members of EAMG support the educational activities during the annual meeting of the European Academy of Allergy and Clinical Immunology with several symposia focusing on the potential and benefits of allergen specific immunotherapy. During symposia arranged by members of EAMG the latest products and treatment concepts for administration of allergen vaccines are discussed.

The following symposia are planned for the next EAACI meeting:

SUNDAY 6 JUNE
10.30 – 12.00
Company Sponsored Symposium -Stallergenes

Chairs : Peter Howarth, United Kingdom Pascal Demoly, France

Lessons learned from the 5-grass SLIT tablet clinical development trials Randolf Brehler, Germany
Sustained effect of the pre/co seasonal treatment with the 5-grass SLIT tablet Hans-Jørgen Malling, Denmark
Clinical relevance of the 5-grass SLIT tablet in the treatment of severe uncontrolled grass-pollen allergic rhinitis patients Pascal Demoly, France

MONDAY 7 JUNE
15.30 – 17.00
Company Sponsored Symposium – Allergopharma High dose specific immunotherapy (SIT): conditions for success
Chair: Roy Gerth van Wijk, The Netherlands
High dose hypoallergenic SCIT Anthony Frew, United Kingdom
High dose SLIT Antonio Nieto, Spain
SIT: current best and future risk reduction Ulrich Wahn, Germany

TUESDAY 8 JUNE
 13.30 – 15.00
Company Sponsored Symposium – ALK Disease-modifying effect of specific immunotherapy – control, sustain, prevent
Chair Adnan Custovic, United Kingdom
Effective disease control with SIT -can we offer our patients more? Natalija Novak, Germany
Sustained disease control with SIT -do we really treat the cause? Stephen Durham, United Kingdom
Preventive effect of SIT -can we stop our patients walking the Allergic March? Eric Bateman, South Africa
Changing the management of allergy -the future is in our hands Henrik Jacobi, Denmark

The Business Meeting of the Immunotherapy Interest Group is arranged Sunday 13.00 -15.00

The general programme includes many activities directed towards allergen specific immunotherapy - om Wednesday morning is arranged the following symposium summarising headlines of the issue.

WEDNESDAY 9 JUNE
08.30 – 10.00 Plenary Symposium 7 -Immunotherapy past, present and future
Chairs: Walter Canonica, Italy Barbara Bohle, Austria
Mechanisms Cezmi Akdis, Switzerland
Indications Hans-Jørgen Malling, Denmark
SCIT versus SLIT for severe allergic rhinitis Stephen Durham, United Kingdom
Future developments in immunotherapy Rudolf Valenta, Austria